Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing-Reference-Cited by-同舟云学术

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing

Published:2015-01-09 Issue:8 Volume:24 Page:2318-2329
ISSN:1460-2083
Container-title:Human Molecular Genetics
language:en
Short-container-title:

Author:

Kunstman John W.,Juhlin C. Christofer,Goh Gerald,Brown Taylor C.,Stenman Adam,Healy James M.,Rubinstein Jill C.,Choi Murim,Kiss Nimrod,Nelson-Williams Carol,Mane Shrikant,Rimm David L.,Prasad Manju L.,Höög Anders,Zedenius Jan,Larsson Catharina,Korah Reju,Lifton Richard P.,Carling Tobias

Publisher

Oxford University Press (OUP)

Subject

Genetics (clinical),Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/hmg/article-pdf/24/8/2318/14147648/ddu749.pdf

Reference64 articles.

1. Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer;Ragazzi;Int. J. Endocrinol.,2014

2. Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies;Smallridge;Endocr. Relat. Cancer,2009

3. Anaplastic thyroid carcinoma: a 50-year experience at a single institution;McIver;Surgery,2001

4. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer;Smallridge;Thyroid,2012

5. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients;Sugitani;World J. Surg.,2012

Cited by 293 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EIF1AX mutation in thyroid nodules: a histopathologic analysis of 56 cases in the context of institutional practices;Virchows Archiv;2024-09-03

2. PD-L1 and B7-H3 are Effective Prognostic Factors and Potential Therapeutic Targets for High-Risk Thyroid Cancer;Endocrine Pathology;2024-08-05

3. The relationship between the gut microbiota and thyroid disorders;Nature Reviews Endocrinology;2024-06-21

4. Promising Therapeutic Targets for Recurrent/Metastatic Anaplastic Thyroid Cancer;Current Treatment Options in Oncology;2024-06-12

5. Nearly Half of Patients with Anaplastic Thyroid Cancer May Be Amenable to Immunotherapy;Biomedicines;2024-06-12